Real-world evidence of health outcomes and medication use 24 months after bariatric surgery in the public healthcare system in Brazil: a retrospective, single-center study

OBJECTIVES: The number of bariatric procedures has significantly increased in Brazil, especially in the public Unified Health System. The present study describes health outcomes and medication use in obese patients treated in a major hospital that performs publicly funded surgery in Brazil. METHODS: A retrospective, single center study was conducted to collect real-world evidence of health outcomes and medication use in 247 obese patients (female, 82.2%) who underwent open Roux-en-Y gastric bypass. Changes in weight and body mass index (BMI), presence of apnea, hypertension, and type 2 diabetes (T2D), and medication use (hypertension, diabetes, and dyslipidemia) were assessed preoperatively and up to 24 months postoperatively. The mean cost of medications was calculated for the 12-month preoperative and 24-month postoperative periods. RESULTS: During the surgery, the mean age of patients was 43.42 years (standard deviation [SD], 10.9 years), and mean BMI was 46.7 kg/m2 (SD, 6.7 kg/m2). At 24 months, significant declines were noted in weight (mean, -37.6 kg), BMI (mean, -14.3 kg/m2); presence of T2D, hypertension, and apnea (-29.6%, -50.6%, and -20.9%, respectively); and number of patients using medications (-66.67% for diabetes, -41.86% for hypertension, and -55.26% for dyslipidemia). The mean cost of medications (total costs for all medications) decreased by >50% in 12-24 postoperative months compared to that in 12 preoperative months. CONCLUSION: Roux-en-Y gastric bypass successfully reduced weight, BMI, and comorbidities and medication use and cost at 24 months in Brazilian patients treated in the public Unified Health System.

Saved in:
Bibliographic Details
Main Authors: Pajecki,Denis, Kawamoto,Flavio, Dantas,Anna Carolina Batista, Andrade,Priscila Caldeira, Brasil,Nissia Capello, Junqueira,Silvio Mauro, Oliveira,Fernanda Maria Pirozelli de, Ribeiro,Rodrigo Antonini, Santo,Marco Aurelio
Format: Digital revista
Language:English
Published: Faculdade de Medicina / USP 2020
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322020000100228
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1807-59322020000100228
record_format ojs
spelling oai:scielo:S1807-593220200001002282020-04-07Real-world evidence of health outcomes and medication use 24 months after bariatric surgery in the public healthcare system in Brazil: a retrospective, single-center studyPajecki,DenisKawamoto,FlavioDantas,Anna Carolina BatistaAndrade,Priscila CaldeiraBrasil,Nissia CapelloJunqueira,Silvio MauroOliveira,Fernanda Maria Pirozelli deRibeiro,Rodrigo AntoniniSanto,Marco Aurelio Open Roux-en-Y Gastric Bypass Healthcare Costs Real-World Evidence Delivery of Healthcare OBJECTIVES: The number of bariatric procedures has significantly increased in Brazil, especially in the public Unified Health System. The present study describes health outcomes and medication use in obese patients treated in a major hospital that performs publicly funded surgery in Brazil. METHODS: A retrospective, single center study was conducted to collect real-world evidence of health outcomes and medication use in 247 obese patients (female, 82.2%) who underwent open Roux-en-Y gastric bypass. Changes in weight and body mass index (BMI), presence of apnea, hypertension, and type 2 diabetes (T2D), and medication use (hypertension, diabetes, and dyslipidemia) were assessed preoperatively and up to 24 months postoperatively. The mean cost of medications was calculated for the 12-month preoperative and 24-month postoperative periods. RESULTS: During the surgery, the mean age of patients was 43.42 years (standard deviation [SD], 10.9 years), and mean BMI was 46.7 kg/m2 (SD, 6.7 kg/m2). At 24 months, significant declines were noted in weight (mean, -37.6 kg), BMI (mean, -14.3 kg/m2); presence of T2D, hypertension, and apnea (-29.6%, -50.6%, and -20.9%, respectively); and number of patients using medications (-66.67% for diabetes, -41.86% for hypertension, and -55.26% for dyslipidemia). The mean cost of medications (total costs for all medications) decreased by >50% in 12-24 postoperative months compared to that in 12 preoperative months. CONCLUSION: Roux-en-Y gastric bypass successfully reduced weight, BMI, and comorbidities and medication use and cost at 24 months in Brazilian patients treated in the public Unified Health System.info:eu-repo/semantics/openAccessFaculdade de Medicina / USPClinics v.75 20202020-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322020000100228en10.6061/clinics/2020/e1588
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Pajecki,Denis
Kawamoto,Flavio
Dantas,Anna Carolina Batista
Andrade,Priscila Caldeira
Brasil,Nissia Capello
Junqueira,Silvio Mauro
Oliveira,Fernanda Maria Pirozelli de
Ribeiro,Rodrigo Antonini
Santo,Marco Aurelio
spellingShingle Pajecki,Denis
Kawamoto,Flavio
Dantas,Anna Carolina Batista
Andrade,Priscila Caldeira
Brasil,Nissia Capello
Junqueira,Silvio Mauro
Oliveira,Fernanda Maria Pirozelli de
Ribeiro,Rodrigo Antonini
Santo,Marco Aurelio
Real-world evidence of health outcomes and medication use 24 months after bariatric surgery in the public healthcare system in Brazil: a retrospective, single-center study
author_facet Pajecki,Denis
Kawamoto,Flavio
Dantas,Anna Carolina Batista
Andrade,Priscila Caldeira
Brasil,Nissia Capello
Junqueira,Silvio Mauro
Oliveira,Fernanda Maria Pirozelli de
Ribeiro,Rodrigo Antonini
Santo,Marco Aurelio
author_sort Pajecki,Denis
title Real-world evidence of health outcomes and medication use 24 months after bariatric surgery in the public healthcare system in Brazil: a retrospective, single-center study
title_short Real-world evidence of health outcomes and medication use 24 months after bariatric surgery in the public healthcare system in Brazil: a retrospective, single-center study
title_full Real-world evidence of health outcomes and medication use 24 months after bariatric surgery in the public healthcare system in Brazil: a retrospective, single-center study
title_fullStr Real-world evidence of health outcomes and medication use 24 months after bariatric surgery in the public healthcare system in Brazil: a retrospective, single-center study
title_full_unstemmed Real-world evidence of health outcomes and medication use 24 months after bariatric surgery in the public healthcare system in Brazil: a retrospective, single-center study
title_sort real-world evidence of health outcomes and medication use 24 months after bariatric surgery in the public healthcare system in brazil: a retrospective, single-center study
description OBJECTIVES: The number of bariatric procedures has significantly increased in Brazil, especially in the public Unified Health System. The present study describes health outcomes and medication use in obese patients treated in a major hospital that performs publicly funded surgery in Brazil. METHODS: A retrospective, single center study was conducted to collect real-world evidence of health outcomes and medication use in 247 obese patients (female, 82.2%) who underwent open Roux-en-Y gastric bypass. Changes in weight and body mass index (BMI), presence of apnea, hypertension, and type 2 diabetes (T2D), and medication use (hypertension, diabetes, and dyslipidemia) were assessed preoperatively and up to 24 months postoperatively. The mean cost of medications was calculated for the 12-month preoperative and 24-month postoperative periods. RESULTS: During the surgery, the mean age of patients was 43.42 years (standard deviation [SD], 10.9 years), and mean BMI was 46.7 kg/m2 (SD, 6.7 kg/m2). At 24 months, significant declines were noted in weight (mean, -37.6 kg), BMI (mean, -14.3 kg/m2); presence of T2D, hypertension, and apnea (-29.6%, -50.6%, and -20.9%, respectively); and number of patients using medications (-66.67% for diabetes, -41.86% for hypertension, and -55.26% for dyslipidemia). The mean cost of medications (total costs for all medications) decreased by >50% in 12-24 postoperative months compared to that in 12 preoperative months. CONCLUSION: Roux-en-Y gastric bypass successfully reduced weight, BMI, and comorbidities and medication use and cost at 24 months in Brazilian patients treated in the public Unified Health System.
publisher Faculdade de Medicina / USP
publishDate 2020
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322020000100228
work_keys_str_mv AT pajeckidenis realworldevidenceofhealthoutcomesandmedicationuse24monthsafterbariatricsurgeryinthepublichealthcaresysteminbrazilaretrospectivesinglecenterstudy
AT kawamotoflavio realworldevidenceofhealthoutcomesandmedicationuse24monthsafterbariatricsurgeryinthepublichealthcaresysteminbrazilaretrospectivesinglecenterstudy
AT dantasannacarolinabatista realworldevidenceofhealthoutcomesandmedicationuse24monthsafterbariatricsurgeryinthepublichealthcaresysteminbrazilaretrospectivesinglecenterstudy
AT andradepriscilacaldeira realworldevidenceofhealthoutcomesandmedicationuse24monthsafterbariatricsurgeryinthepublichealthcaresysteminbrazilaretrospectivesinglecenterstudy
AT brasilnissiacapello realworldevidenceofhealthoutcomesandmedicationuse24monthsafterbariatricsurgeryinthepublichealthcaresysteminbrazilaretrospectivesinglecenterstudy
AT junqueirasilviomauro realworldevidenceofhealthoutcomesandmedicationuse24monthsafterbariatricsurgeryinthepublichealthcaresysteminbrazilaretrospectivesinglecenterstudy
AT oliveirafernandamariapirozellide realworldevidenceofhealthoutcomesandmedicationuse24monthsafterbariatricsurgeryinthepublichealthcaresysteminbrazilaretrospectivesinglecenterstudy
AT ribeirorodrigoantonini realworldevidenceofhealthoutcomesandmedicationuse24monthsafterbariatricsurgeryinthepublichealthcaresysteminbrazilaretrospectivesinglecenterstudy
AT santomarcoaurelio realworldevidenceofhealthoutcomesandmedicationuse24monthsafterbariatricsurgeryinthepublichealthcaresysteminbrazilaretrospectivesinglecenterstudy
_version_ 1756432350402576384